Background/Aim: The impact of dialysis membrane permeability on neutrophil transmigration properties in vitro was examined in the present study. This issue has not been fully scrutinized before. Methods: We studied the capacity of neutrophils collected from a group of dialysis patients randomly treated with cuprophan, low- or high-flux polysulfone, to transmigrate in vitro through a membrane covered with fibronectin (a main constituent of the endothelial basement membrane). The hemodialysis-induced quantitative changes in expression of adhesion molecules were examined in parallel. Results: At the end of dialysis, neutrophils collected from patients treated with high-flux polysulfone dialyzers had a significantly higher transmigration index than neutrophils from patients treated with low-flux polysulfone membrane (p < 0.01) or cuprophan membrane (p < 0.01), and approached the level of transmigration observed in neutrophils collected from healthy controls. In the groups treated with low-flux polysulfone and cuprophan dialyzers, the transmigration capacity was significantly lower (p < 0.02) compared to neutrophils from healthy subjects. We also noted that differences between low- and high-flux polysulfone dialysis, in the context of transmigration properties, were not mirrored by changes in adhesion phenotype, which strengthens the view that there is no strict relationship between these two features. Conclusion: The study demonstrates that high-flux polysulfone dialysis, as opposed to low-flux polysulfone and cuprophan treatment, improves the transmigration properties of circulating neutrophils, despite similar effects on adhesion molecule phenotypes. A plausible mechanism is that potentially toxic middle range molecules that inhibit neutrophil migration are more efficiently eliminated during high-flux polysulfone dialysis, but this explanation requires further support.

Keywords:
Neutrophil, Transmigration, Hemodialysis membrane, Fibronectin
1.
Lawrence MB, Springer TA: Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859–873.
2.
Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068–2101.
3.
Cybulsky MI, McComb DJ, Movat HZ: Protein synthesis dependent and independent mechanisms of neutrophil emigration. Different mechanisms of inflammation in rabbits induced by interleukin-1, tumor necrosis factor α or endotoxin versus leukocyte chemoattractants. Am J Pathol 1989;135:227–237.
4.
Stanislawski L, Huu TP, Perianin A: Priming effect of fibronectin on respiratory burst of human neutrophils induced by formyl peptides and platelet-activating factor. Inflammation 1990;14:523–530.
5.
Walsh GM, Symon FA, Wardlaw AJ: Human eosinophils preferentially survive on tissue fibronectin compared to plasma fibronectin. Clin Exp Allergy 1995;25:1128–1136.
6.
Chenoweth DE, Cheung AK, Henderson LW: Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int 1983;24:764–769.
7.
Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS: Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977;296:769–774.
8.
Hakim RM, Schafer AI: Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 1985;78:575–580.
9.
Himmelfarb J, Zaoui P, Hakim R: Modulation of granulocyte LAM-1 and MAC-1 during dialysis: A prospective, randomized controlled trial. Kidney Int 1992;41:388–395.
10.
Thylén P, Fernvik E, Lundahl J, Hed J, Jacobson SH: Cell surface receptor modulation on monocytes and granulocytes during clinical and experimental hemodialysis. Am J Nephrol 1995;15:392–400.
11.
Thorlacius H, Fernvik E, Gautam N, Lundahl J, Raud J, Jacobson SH, Lindbom L: Impaired leukocyte rolling, adhesion and transendothelial migration following cuprophan haemodialysis. Acta Physiol Scand 1997;159:277–283.
12.
Van Tejlingen ME, Borgdorff P, van Wijhe, van Lambalgen TA, Ter Wee PE, Tangelder GJ: In vivo visualization of hemodialysis-induced alterations in leukocyte-endothelial interactions. Kidney Int 2000;57:2608–2617.
13.
Thylén P, Fernvik E, Haegerstrand A, Lundahl J, Jacobson SH: Dialysis-induced serum factors inhibit adherence of monocytes and granulocytes to adult human endothelial cells. Am J Kidney Dis 1997;29:78–85.
14.
Himmelfarb J, Tolkoff Rubin N, Chandran P, Parker RA, Wingard RL, Hakim R: A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 1998;9:257–266.
15.
Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096–1101.
16.
Halldén G, Nopp A, Ihre E, Peterson C, Lundahl J: Conditions in blood sampling procedures that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls. Ann Allergy Asthma Immunol 1999;83:413–421.
17.
Halldén G, Hed J: The FOG method. A new approach to detecting activated eosinophils. ACI News 1993;5:139–143.
18.
Hed J, Halldén G: Counts of activated blood eosinophils for monitoring asthma. Allergy 1993;48:87–93.
19.
Moshfegh A, Halldén G, Lundahl J: Methods for simultaneous quantitative analysis of eosinophil and neutrophil adhesion and transmigration. Scand J Immunol 1999;50:262–269.
20.
Bochner BS: Cellular adhesion and its antagonism. J Allergy Clin Immunol 1997;100:581–585.
21.
Thylén P, Fernvik E, Lundahl J, Hed J, Jacobson SH: Modulation of CD11b/CD18 on monocytes and granulocytes following hemodialysis membrane interaction in vitro. Int J Artif Organs 1996;19:156–163.
22.
Alvarez V, Pulido R, Campanero MR, Paraiso V, de Landazuri MO, Sanchez-Madrid F: Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int 1991;40:899–905.
23.
Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacob HS: Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977;59:879–888.
24.
Skroeder NR, Kjellstrand P, Holmquist B, Kjellstrand CM, Jacobson SH: On complement net generation in fast hemodialysis: Are high blood flow rates bioincompatible? Am J Kidney Dis 1995;25:896–903.
25.
Snyderman R, Pike MC: Chemoattractant receptors on phagocytic cells. Annu Rev Immunol 1984;2:257–281.
26.
Collins PD, Marleau S, Griffiths-Johnson A, Jose PJ, Williams TJ: Co-operation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:1169–1174.
27.
Mould AW, Matthaei KI, Young IG, Foster PS: Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997;99:1064–1071.
28.
Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AE, Wells TN, Li D, Jeffery PK, Griffiths-Johnson DA, Williams TJ, Jose PJ: Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo. J Exp Med 1997;186:601–612.
29.
Bohnsack JF, Zhou XN: Divalent cation substitution reveals CD18- and very late antigen-dependent pathways that mediate human neutrophil adherence to fibronectin. J Immunol 1992;149:1340–1347.
30.
Matsumoto K, Sterbinsky SA, Bickel CA, Zhou DF, Kovach NL, Bochner BS: Regulation of α4 integrin-mediated adhesion of human eosinophils to fibronectin and vascular cell adhesion molecule-1. J Allergy Clin Immunol 1997;99:648–656.
31.
Damsky CH, Werb Z: Signal transduction by integrin receptors for extracellular matrix: Co-operation processing of extracellular information. Curr Biol 1997;4:772–781.
32.
Vanholder R, De Smet R, Hsu C, Vogeleere P, Ringoir S: Uremic toxicity: The middle molecule hypothesis revisited. Semin Nephrol 1994;14:205–218.
33.
Hörl WH, Haag-Weber M, Georgopoulos A, Block LH: Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci USA 1990;87:6353–6357.
34.
Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992;3:1227–1237.
35.
Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini G: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996;50:1293–1302.
36.
Locatelli F, Hannedouche T, Jacobson S, La Greca G, Loureiro A, Martin-Malo A, Papadimitriou M, Vanholder R: The effect of membrane permeability on ESRD: Design of a prospective randomised multicentre trial. J Nephrol 1999;12:85–88.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.